Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.

Stem cells are under strict regulation by both intrinsic factors and the microenvironment. There is increasing evidence that many cancers initiate through acquisition of genetic mutations (loss of intrinsic control) in stem cells or their progenitors, followed by alterations of the surrounding microenvironment (loss of extrinsic control). In neurofibromatosis type 1 (NF1), deregulation of Ras signaling results in development of multiple neurofibromas, complex tumors of the peripheral nerves. Neurofibromas arise from the Schwann cell lineage following loss of function at the NF1 locus, which initiates a cascade of interactions with other cell types in the microenvironment and additional cell autonomous modifications. In this study, we sought to identify whether a temporal "window of opportunity" exists during which cells of the Schwann cell lineage can give rise to neurofibromas following loss of NF1. We showed that acute loss of NF1 in both embryonic and adult Schwann cells can lead to neurofibroma formation. However, the embryonic period when Schwann cell precursors and immature Schwann cells are most abundant coincides with enhanced susceptibility to plexiform neurofibroma tumorigenesis. This model has important implications for understanding early cellular events that dictate neurofibroma development, as well as for the development of novel therapies targeting these tumors.

[1]  Jiaoti Huang,et al.  Identification of a Cell of Origin for Human Prostate Cancer , 2010, Science.

[2]  B. Tysnes,et al.  Tumor-initiating and -propagating cells: cells that we would like to identify and control. , 2010, Neoplasia.

[3]  Rosalie E Ferner Neurofibromatosis 1 , 2010, European Journal of Human Genetics.

[4]  E. Fabbri,et al.  Pseudoxanthoma-elasticum-like syndrome and thalassemia: an update. , 2009, Dermatology online journal.

[5]  D. Burns,et al.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. , 2009, Cell stem cell.

[6]  E. Rallis,et al.  Giant plexiform neurofibroma in a patient with neurofibromatosis type I. , 2009, Dermatology online journal.

[7]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[8]  Arturo Alvarez-Buylla,et al.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. , 2009, Cancer cell.

[9]  P. Nelson,et al.  Retentive Multipotency of Adult Dorsal Root Ganglia Stem Cells , 2009, Cell transplantation.

[10]  N. Ratner,et al.  How does the Schwann cell lineage form tumors in NF1? , 2008, Glia.

[11]  L. Sommer,et al.  Development of the Schwann cell lineage: From the neural crest to the myelinated nerve , 2008, Glia.

[12]  G. Hutchins,et al.  Nf1-Dependent Tumors Require a Microenvironment Containing Nf1 +/−- and c-kit-Dependent Bone Marrow , 2008, Cell.

[13]  S. Morrison,et al.  The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. , 2008, Cancer cell.

[14]  A. Stemmer-Rachamimov,et al.  Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. , 2008, Cancer cell.

[15]  D. Burns,et al.  Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. , 2008, Cancer cell.

[16]  P. Sheard,et al.  Developmental loss of NT‐3 in vivo results in reduced levels of myelin‐specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells , 2008, Glia.

[17]  Xin-Fu Zhou,et al.  Isolation and Characterization of Neural Crest Progenitors from Adult Dorsal Root Ganglia , 2007, Stem cells.

[18]  L. Parada,et al.  Tumor microenvironment and neurofibromatosis type I: connecting the GAPs , 2007, Oncogene.

[19]  D. Evans,et al.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 , 2006, Journal of Medical Genetics.

[20]  D. Kaplan,et al.  Analysis of the neurogenic potential of multipotent skin-derived precursors , 2006, Experimental Neurology.

[21]  AB Trovó‐Marqui,et al.  Neurofibromin: a general outlook , 2006, Clinical genetics.

[22]  Jeff Biernaskie,et al.  Skin-Derived Precursors Generate Myelinating Schwann Cells for the Injured and Dysmyelinated Nervous System , 2006, The Journal of Neuroscience.

[23]  U. Suter,et al.  ErbB2 Signaling in Schwann Cells Is Mostly Dispensable for Maintenance of Myelinated Peripheral Nerves and Proliferation of Adult Schwann Cells after Injury , 2006, The Journal of Neuroscience.

[24]  R. Mirsky,et al.  The origin and development of glial cells in peripheral nerves , 2005, Nature Reviews Neuroscience.

[25]  F. Miller,et al.  Isolation and Characterization of Multipotent Skin‐Derived Precursors from Human Skin , 2005, Stem cells.

[26]  D. Gutmann,et al.  Neurofibromatosis 1: from lab bench to clinic. , 2005, Pediatric neurology.

[27]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[28]  Philipp Berger,et al.  Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells , 2003, Molecular and Cellular Neuroscience.

[29]  D. Burns,et al.  Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment , 2002, Science.

[30]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[31]  A. Sadikot,et al.  Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.

[32]  L. Parada,et al.  Neurofibromin, a tumor suppressor in the nervous system. , 2001, Experimental cell research.

[33]  T. Jacks,et al.  NF1 Tumor Suppressor Gene Function Narrowing the GAP , 2001, Cell.

[34]  G. Tennekoon,et al.  Neurofibromatosis type 1 I. General overview , 2000, Journal of neuroscience research.

[35]  V. Riccardi,et al.  Associations of clinical features in neurofibromatosis 1 (NF1) , 2000, Genetic epidemiology.

[36]  Karlyne M. Reilly,et al.  Mouse models of tumor development in neurofibromatosis type 1. , 1999, Science.

[37]  S. Velasco-Miguel,et al.  Mouse tumor model for neurofibromatosis type 1. , 1999, Science.

[38]  U. Suter,et al.  P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. , 1999, Development.

[39]  David J. Anderson,et al.  Prospective Identification, Isolation by Flow Cytometry, and In Vivo Self-Renewal of Multipotent Mammalian Neural Crest Stem Cells , 1999, Cell.

[40]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[41]  H. Armah Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model , 2010 .

[42]  R. Feil,et al.  Inducible Cre mice. , 2009, Methods in molecular biology.

[43]  Philippe Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[44]  B. R. Korf,et al.  Plexiform neurofibromas. , 1999, American journal of medical genetics.

[45]  E. B. Prophet,et al.  Laboratory methods in histotechnology , 1992 .